A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)

NCT00779129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Pegylated Lyposomal Doxorubicin
DRUG: Cyclophosphamide

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]